Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

BACKGROUND: Fluticasone furoate is a once-daily inhaled corticosteroid. This report provides an overview of safety and efficacy data that support the use of once-daily fluticasone furoate 100 μg or 200 μg in adult and adolescent asthma patients. METHODS: Fourteen clinical studies (six Phase II and e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Respir Res
Egile Nagusiak: O’Byrne, Paul M., Jacques, Loretta, Goldfrad, Caroline, Kwon, Namhee, Perrio, Michael, Yates, Louisa J., Busse, William W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122018/
https://ncbi.nlm.nih.gov/pubmed/27881132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0473-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak